KR7068760008
KR7068760008
Celltrionph
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.72T EUR | 1.83T EUR | 2.55T EUR | 2.57T EUR |
Enterprise Value | 1.88T EUR | 1.94T EUR | 2.66T EUR | 2.68T EUR |
Valuation Multiples | ||||
Trailing P/E | -- | 42.63x | 63.45x | 81.74x |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 6.25x | 3.16x | 4.59x | 6.06x |
Price to Book | -- | 4.07x | 5.87x | 5.89x |
EV/Revenue | 6.83x | 3.35x | 4.78x | 6.32x |
EV/EBITDA | 43.86x | 22.31x | 32.02x | 42.3x |
Price to FCF (P/FCF) | -- | 39.71x | 48.72x | 75.59x |
EV/FCF | -- | 42.06x | 50.7x | 78.86x |
FCF Yield | -1.17% | 2.52% | 2.05% | 1.32% |